Antihypertensive effect of alpha lipoic acid supplementation

Current Topics in Nutraceutical Research

Volumn 2, Issue 3, 2004, Pages 137-152

  Vasdev, Sudesh ^a   Gill, Vicki ^a   Longerich, Linda ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Alpha lipoic acid; Antioxidant; Hypertension; Methylglyoxal

Indexed keywords

ALDEHYDE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; GLIBENCLAMIDE; GLUCOSE; INSULIN; NITRIC OXIDE; PYRIDOXINE; THIOCTIC ACID;

ANIMAL MODEL; ANTIOXIDANT ACTIVITY; BIOCHEMISTRY; BLOOD PRESSURE REGULATION; BODY WEIGHT DISORDER; CARBOHYDRATE DIET; CARDIOVASCULAR DISEASE; CLINICAL EXAMINATION; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; ESSENTIAL HYPERTENSION; GLUCOSE METABOLISM; HISTOPATHOLOGY; HUMAN; HYPOGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; MEDICAL RESEARCH; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; RAT; REVIEW; SALT INTAKE; VASCULAR RESISTANCE;

ANIMALIA;

EID: 4143111402     PISSN: 15407535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (159)

1. Alexander MC, Lomanto M, Nasrin N, Ramaika C. (1988) Insulin stimulates glyceraldehydes-3-phosphate dehydrogenase gene expression through CIS-acting DNA sequences. Proceedings of the National Academy of Sciences 85: 5092-5096.
2. Androne L, Gavan NA, Veesiu IA, Orasan R. (2000) In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy. In Vivo 14: 327-330.
3. Aoki K, Kawaguchi Y, Sato K, Kondo S, Yamamoto M. 1982. Clinical and pharmacological properties of calcium antagonists in essential hypertension in humans and spontaneously hypertensive rats. Journal of Cardiovascular Pharmacology 4: S298-S302.
4. Appel LJ, Moore, TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt M, Cutler JA, Windhauser MM, Lin P-H, Karanja N. (2001) A clinical trial of the effects of dietary patterns on blood pressure. New England Journal of Medicine 336: 1117-1124
5. Asagami T, Reaven GM, Tsao, PS. (1999) Enhanced monocyte adherence to thoracic aortae from rats with two forms of experimental hypertension. American Journal of Hypertension 12: 890-893.
6. Barbagallo M, Dominguez LJ, Tagliamonte MR, Resnick LM, Paolisso G. (1999) Effect of vitamin E and glutathione on glucose metabolism. Role of magnesium. Hypertension 34 (part 2): 1002-1006.
7. Beckman JS, Koppenol WH. (1996) Nitric oxide, superoxide and peroxynitrite: the good, the bad and ugly. American Journal of Physiology 271: C1424-1437.
8. Beck-Neilsen H, Pedersen O, Lindskov HO. (1980) Impaired cellular insulin binding and insulin sensitivity induced by high fructose feeding in normal subjects. American Journal of Clinical Nutrition 33: 273-278.
9. Benedetti A, Comporti M, Esterbauer H. (1980) Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochimica et Biophysica Acta 620: 281-296.
10. Bigazzi R, Bianchi S, Baldari G, Campese VM. (1996) Clustering of Cardiovascular Risk factors in salt-sensitive patients with essential hypertension: Role of insulin. American Journal of Hypertension 9:24-32.
11. Blaustein MR (1977) Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. American Journal of Physiology 232: C165-C173.
12. Bohr DF. (1963)Vascular smooth muscle: dual effect of calcium. Science 139: 597-599.
13. Bolton TB. (1979) Mechanisms of action of transmitters and other substances on smooth muscle. Physiological Reviews 59: 606-718.
14. Borcea V, Nourooz-Zadeh J, Wolff SP, Klevesath M, Hofmann M, Urich H, Wahl P, Ziegler R, Tritschler H, Halliwell B, Naeroth PP. (1999) Alpha-lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radical Biology and Medicine 26: 1495-1500.
15. Boshtam M, Rafiei M, Sadeghi K, Zadegan-Sarraf N. (2002) Vitamin E can reduce blood pressure in mild hypertensives. International Journal for Vitamin and Nutrition Research 72: 309-314.
16. Brandwein HJ, Lewicki JA, Murad E (1981) Reversible inactivation of guanylate cyclase by mixed disulfide formation. Journal of Biological Chemistry 256: 2958-2962.
17. Brooks BR, Klamerth OJ. (1968) Interaction of DNA with bifunctional aldehydes. European Journal of Biochemistry 5: 178-182.
18. Busse E, Zimmer G, Schopohl B, Kornhuber B. (1992) Influence of ?-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittel-Forschung 42: 829-831.
19. Ceriello A, Guigliano D, Quatraro A, LeFebvre PJ. (1991) Anti-oxidants show an antihypertensive effect in diabetic and hypertensive subjects. Clinical Science 81: 739-742.
20. Chang KC, Paek KS, Kim HJ, Lee YS, Yabe-Nishimura C, Seo HG. (2002) Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Molecular Pharmacology 61: 1184-1191.
21. Coombes JS, Powers SK, Hamilton KL, Demirel HA, Shanely RA, Zergeroglu MA, Sen CK, Packer L, Ji LL. (2000) Improved performance after ischemia in aged rats supplemented with vitamin E and lipoic acid. American Journal of Physiology (Regulatory Integrative, and Comparative Physiology) 279: R2149-2155.
22. Costagliola C, Libondi T, Menzione M, Rinaldi E, Auricchio G. (1985) Vitamin E and red blood cell glutathione. Metabolism 34 (8): 712-714.
23. Dargel R. (1992) Lipid peroxidation - a common pathogenetic mechanism? Experimental Toxicological Pathology 44: 169-181
24. DeFronzo R, Ferrannini E. (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194.
25. Degenhardt TP, Thorpe SR, Baynes JW (1998) Chemical modification of proteins by methylglyoxal. Cellular and Molecular Biology 44: 1139-1145.
26. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. (1987) Insulin resistance in essential hypertension. New England Journal of Medicine 313: 350-357
27. Filo RS, Bohr DF, Ruegg JC. (1965) Glycerinated skeletal and smooth muscle: calcium and magnesium dependence. Science 147:1581-1583.
28. Fuenmayor N, Moreira. E, Cubeddu LX. (1998) Salt sensitivity is associated with insulin resistance in essential hypertension. American Journal of Hypertension 4: 397-402.
29. Giner V, Coca A, de la Sierra A. (2001) Increased insulin resistance in salt sensitive essential hypertension. Journal of Human Hypertension 15:481-485.
30. Giugliano D, Ceriello A, Paolisso G. (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267.
31. González-Albarrán O, Ŕuilope LM, Villa E, Robles RG. (1998) Salt sensitivity: Concept and pathogenesis. Diabetes Research and Clinical Practice (suppl 39): S15-S26.
32. Grant WB. (1998) Reassessing the role of sugar in the etiology of heart disease. Journal of Orthomolecular Medicine 13(2):95-104.
33. Grant WB. (1999) Low-fat, high-sugar diet and lipoprotein profiles. American Journal of Clinical Nutrition 70:1111-1113.
34. Hallfrisch J, Ekkwood KC, Michaelic OE, Reiser S, O'Dorisio TM, Prather ES. (1983) Effects of dietary fructose on plasma glucose and hormone responses in normal and hyperinsulinemic men. Journal of Nutrition 113: 1819-1826.
35. Han D, Handelman G, Marcocci L, Sen CK, Roy S, Kobuchi H, Tritschler HJ, Flohe L, Packer L. (1997) Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. BioFactors 6: 321-338.
36. Hofmann M, Mainka P, Tritshler H, Fuchs J, Zimmer G. (1995) Decrease of red cell membrane fluidity and -SH groups due to hyperglycemic conditions is counteracted by ?-lipoic acid. Archives of Biochemistry and Biophysics 324: 85-92.
37. Hulman S, Falkner B, Freyvogel N. (1993) Insulin resistance in the conscious spontaneously hypertensive rat: Euglycemic hyperinsulinemic clamp study. Metabolism 42:14-18.
38. Hwang IS, Ho H, Hoffman BB, Reaven GM. (1987) Fructose-induced insulin resistance and hypertension in rats. Hypertension 10:512-516
39. Ibarra M, Meneses A, Ransanz V, Castillo C, Hong E. (1995) Changes in endothelium-dependent vascular responses associated with spontaneous hypertension and age in rats. Archives of Medical Research 26: S177-S183.
40. Israel KD, Michaelis OE, Reiser S, Keeney M. (1983) Serum uric acid, inorganic phosphorus, and glutamic-oxalacetic transaminase and blood pressure in carbohydrate-sensitive adults consuming three different levels of sucrose. Annals of Nutrition and Metabolism 27:425-435.
41. Ivanov VN. (1974) Effect of lipoic acid on tissue respiration in rabbits with experimental atherosclerosis. Cor et Vasa 16: 141-150.
42. Ives HE. (1989) Ion transport defects and hypertension. Where is the link? Hypertension 14: 590-597.
43. Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, Rett K. (1999) Oral administration of RAC-?-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: A placebo controlled pilot trial. Free Radical Biology & Medicine 27: 309-314.
44. Janero DR, Burghardt B. (1989) Cardiac membrane vitamin E and malondialdehyde levels in heart muscle of normotensive and spontaneously-hypertensive rats. Lipids 24: 33-38.
45. Jellin JM, Gregory PJ, Batz F, Hitchens K, eds. (2002) In: Natural Medicine Comprehensive Database, 4th edition. pp.49.
46. Johnson RK, Frary C. (2001) Choose beverages and foods to moderate your intake of sugars: The 2000 dietary guidelines for Americans - what's all the fuss about. Journal of Nutrition 131:2766S-2771S
47. Julius S. (2000) Five decades of antihypertensive treatment: the unresolved issues. Journal of Hypertension 18 (suppl 3): S3-S7
48. Jun T, Ke-yan F, Catalano M. (1996) Increased superoxide anion production in humans: a possible mechanism for the pathogenesis of hypertension. Journal of Human Hypertension 10: 305-309.
49. Kahn NN, Acharya K, Bhattacharya S, Acharya R, Mazumder S, Bauman WA, Sinha AK.(2000) Nitric oxide: The "second messenger" of insulin. IUBMB Life 49: 441-450.
50. Kamata K, Yamashita K. (1999) Insulin resistance and impaired endothelium-dependent renal vasodilatation in fructose-fed hypertensive rats. Research Communications in Molecular Pathology and Pharmacology 103: 195-210.
51. Kashiwagi A, Obata T, Suzaki M, Takagi Y, Kida Y, Ogawa T, Tanaka Y, Asahina T, Ikebuchi M, Saeki Y. (1992) Increase in cardiac muscle fructose content in streptozotocin-induced diabetic rats. Metabolism 41(10): 1041-1046.
52. Khamaisi M, Rudich A, Potashnik R, Tritschler HJ, Gutman A, Bashan N. (1999) Lipoic acid acutely induces hypoglycemia in fasting nondiabetic and diabetic rats. Metabolism 48: 504-510.
53. Khanna S, Atalay M, Laaksonen DE, Gul M, Roy S, Sen CK. (1999) ?-Lipoic acid supplementation: tissue glutathione homeostasis at rest and after exercise. Journal of Applied Physiology 86: 1191-1196.
54. Koçak G, Aktan F, Canbolat O, Ozogul C, Elbeg S, Yildizoglu AN, Karasu C. (2000) Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes, Nutrition and Metabolism 13: 308-318.
55. Kondoh Y, Kawase M, Ohmori S. (1992) D-lactate concentrations in blood, urine and sweat before and after exercise. European Journal of Applied Physiology 65: 88-93.
56. Konrad T, Vicini P. Kusterer K Hoflich A, Assadkhani A. (1999) ?-Lipoic acid treatment decreases serum lactate and pyruvate concentrations, and improves glucose effectiveness in lean, and obese patients with type 2 diabetes. Diabetes Care 22:280-287.
57. Koska J, Syrova D, Blazicek P, Marko M, Grna JD, Kvetnansky R, Vigas M. (1999) Malodialdehyde, lipofuscin and activity of antioxidant enzymes during physical exercise in patients with essential hypertension. Journal of Hypertension 17: 529-535.
58. Kotchen TA, Zhang HY, Covelli M, Blehschmidt N. (1991) Insulin resistance and blood pressure in Dahl rats, and in one-kidney, one-clip hypertensive rats. American Journal Physiology (Endocrinology and Metabolism) 261: E692-E697.
59. Kumar KV, Das UN. (1993) Are free radicals involved in the pathobiology of human essential hypertension? Free Radical Research Communications 19: 59-66.
60. Lembo G, Iaccarino G, Vecchione C, Rendina V, Trimarco B. (1995) Insulin modulation of vascular reactivity is already impaired in prehypertensive spontaneously hypertensive rats. Hypertension 26:290-293.
61. Leoncini G, Maresca M, Buzzi E. (1989) Inhibition of the glycolytic pathway by methylgloxal in human platelets. Cell Biochemistry and Function 7: 65-70.
62. Levy J, Zemel MB, Sowers JR. (1989) Role of cellular calcium metabolism in abnormal glucose metabolism and diabetic hypertension. American Journal of Medicine 87 (supp 6A): 7S-16S
63. Lieber CS. (1990) Mechanism of ethanol induced hepatic injury. Pharmacology and Therapeutics 46: 1-41.
64. Low PA, Kim K, Tritschler HJ. (1997) The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46 (Suppl.2): S38-S42.
65. Manning RD, Hu L, Tan DY, Meng S. (2001) Role of abnormal nitric oxide systems in salt- sensitive hypertension. American Journal Hypertension 14: 68S-73S.
66. Maritim AC, Sanders RA, Watkins JB. (2003) Effects of ?-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. Journal of Nutritional Biochemistry 14: 288-294.
67. Martinez FJ, Rizza JC, Romero C. (1994) High-fructose feeding elicits insulin resistance, hyperinsulinemia, and hypertension in normal mongrel dogs. Hypertension 23: 456-463.
68. Meister A, Anderson ME, Hwang O. (1986) Intracellular cysteine and glutathione delivery systems. Journal of the American College of Nutrition 5: 137-151.
69. Melhem MF, Craven PA, DeRubertis FR. (2001) Effects of dietary supplementation of alpha-Lipoic acid on early glomerular injury in diabetes mellitus. Journal of the American Society of Nephrology 12: 124-133.
70. Midaoui A, de Champlain J. (2002) Prevention of hypertension, insulin resistance, and oxidative stress by ?-lipoic acid. Hypertension 39: 303-307.
71. Midaoui AE, Elimadi A, Wu L, Haddad PS, de Champlain J. (2003) Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. American Journal of Hypertension 16: 173-179.
72. Miller ER, Simons-Morton DG, Karanja N, Lin P-H. (2001) Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (dash) diet. New England Journal of Medicine 344: 3-10
73. Mondon CE, Reaven GM. (1988) Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension. Metabolism 37: 303-305.
74. Moran JP, Cohen L, Greene JM, Xu G, Feldman EB, Hames CG, Feldman DS. (1993) Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. American Journal of Clinical Nutrition 57: 213-217
75. Morcos M, Borcea V, Isermann B, Gehrke S, Ehret T, Henkels M, Schiekofer S, Hofmann M, Amiral J, Tritschler H, Ziegler R, Wahl P, Nawroth PP (2001) Effect of ?-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Research and Clinical Practice 52: 175-183.
76. Mori Y, Murakawa Y, Yokoyama J, Tajima N, Ikeda Y, Nobukata H, Ishikawa T, Shibutani Y. (1999) Effect of highly purified eicosapentaenoic acid ethyl ester in insulin resistance and hypertension in Dahl salt-sensitive rats. Metabolism 48: 1089-1095.
77. 2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: role of disulfide, sulfhydryl and phosphate groups. Biochimica et Biophysica Acta 1052: 333-339.
78. Murray RK, et al. (2000) Harper's Biochemistry, Twenty-fifth edition, Appleton and Lange, Norwalk, Connecticut, pp 192-193, 225.
79. Nagamatsu M, Nickander KK, Schmelxer JD, Raya A, Wittrock DA, Tritschler, Low PA. (1995) Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18: 1160-1167.
80. Newaz MA, Newal NNA, Rohaizan CH, Muslim N, Gapor A. (1999) ?-Tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats. American Journal of Hypertension 12:839-844.
81. Nikkila EA. (1974) Influences of dietary fructose and sucrose on serum triglycerides in hypertriglyceridemia and diabetes. In: Sipple HL, McNutt KW, eds. Sugars in Nutrition. New York, Academic Press, pp 439-448.
82. Noguchi N, Niki E. (1998) Chemistry of active oxygen species and antioxidants in: Antioxidant status, diet, nutrition and health. Papas AM, ed. CRC Press, Boca Raton, Fl. pp 3-21.
83. Oba T, Yamaguchi M. (1990) Sulfhydryls on frog skeletal muscle membrane participate in contraction. American Journal of Physiology 259:C709-C714.
84. Ogihara T, Asano T, Ando K, Sakoda H, Anai M, Shojima N, Ono H, Onishi Y, Fujishiro M, Abe M, Fukushima Y, Kikuchi M, Fujita T. (2002) High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats. Hypertension 40: 83-89.
85. Packer L, Kraemer L, Rimbach G. (2001) Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17: 888-895.
86. Packer L, Roy S, Sen CK. (1999) ?-Lipoic acid: A metabolic antioxidant and potential redox modulator of transcription. Advances in Pharmacology 38: 79-101.
87. Packer L, Witt EH, Tritschler HJ. (1995) Alpha-lipoic acid as a biological antioxidant. Free Radical Biology and Medicine 19 (2): 227-250.
88. Packer L. (1998) ?-Lipoic acid: A metabolic antioxidant which regulates NF-?B signal transduction and protects against oxidative injury. Drug Metabolism Reviews 30: 245-275.
89. Paolisso G, D'Amore A, Balbi V, Volpe C, Galzerano, D, Giugliano D, Sgambato S, Varrichio M, D'Onofrio E (1994) Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetes. American Journal of Physiology (Endocrinology and Metabolism) 266: E261-E268.
90. Paolisso G, D'Amore A, Giugliano D, Ceriello A, Varricchio M, D'Onofrio E (1993) Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. American Journal of Clinical Nutrition 57: 650-656
91. Paolisso G, Giugliano D. (1996) Oxidative stress and insulin action: is there a relationship? Diabetologia 39: 357-363.
92. Phillips SA, Mirlees D, Thornalley PJ. (1993) Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Effect of the aldose reductase inhibitor statil. Biochemical Pharmacology 46: 805-811.
93. Podda M, Tritschler HJ, Ulrich H, Packer L. (1994) ?-Lipoic acid supplementation prevents symptoms of vitamin E deficiency. Biochemical and Biophysical Research Communications 204: 98-104.
94. Poli G, Dianzani MU, Cheeseman KH, Slater TF, Lang J, Esterbauer H. (1985) Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochemistry Journal 227: 629-638
95. Pontremoli S, Salamino F, Sparatore B, De Tullio R, Patrone M, Tizianello A, Melloni E. (1989) Enhanced activation of the respiratory burst oxidase in neutrophils from hypertensive patients. Biochemical and Biophysical Research Communications 158: 966-972.
96. Prabha PS, Das UN, Koratkar R, Sangeetha Sagar P, Ramesh G. (1990) Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension. Prostaglandins Leukotrienes and Essential Fatty Acids 41:27-33.
97. Preuss HG, el Zein M, Knapka J, MacArthy P, Yousufi. AK, Gleim GW, Glace B, Zukowska-Grojec Z. (1992) Blood pressure responses to sucrose ingestion in four rat strains. American Journal of Hypertension 5: 244-250.
98. Raghuveer G, Sinkey CA, Chenard C, Stumbo P, Haynes WG. (2001) Effect of vitamin E on resistance vessel endothelial dysfunction induced by methionine. American Journal of Cardiology 88: 285-290.
99. Rahman I, Nath N. (1988) Glutathione and its redox system, superoxide anion and superoxide dismutases of polymorphonuclear leukocytes in essential hypertension. Indian Journal of Medical Research 88: 64-70.
100. Reaven GM. (1991) Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. American Journal of Medicine (supp 2A):7S-12S.
101. Reiser S, Handler HB, Gardner LB, Hallfrisch JG, Michaelis OE, Prather ES. (1979) Isocaloric exchange of dietary starch and sucrose in humans. II. Effect on fasting blood insulin, glucose, and glucagon and on insulin and glucose response to a sucrose load. American Journal of Clincal Nutrition 32: 2206-2216.
102. Reiser S, Powell AS, Scholfield DJ, Panda P, Ellwood KC, Canary JJ. (1989) Blood lipids, lipoproteins, apoproteins, and uric acid in men fed diets containing fructose or high-amylose cornstarch. American Journal of Clinical Nutrition 49: 832-839.
103. Robinson BF (1984). Altered calcium handling as a cause of primary hypertension. Journal of Hypertension 2: 453-460.
104. Rocchini AP, Katch V, Kveselis D, Moorehead C, Martin M, Lampman R, Gregory M. (1989) Insulin and renal sodium retention in obese adolescents. Hypertension 14: 367-374.
105. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR,
106. Sagar S, Kallo U, Kaul N, Ganguly NK, Sharma BK. (1992) Oxygen free radicals in essential hypertension. Molecular and Cellular Biochemistry 111: 103-108.
107. Schauenstein E, and Esterbauer, H. (1979) Formation and properties of reactive aldehydes: In Submolecular Biology and Cancer. Excerpta Medica, CIBA Foundation Symposium (67) 225-244.
108. Schauenstein E, Esterbauer H, Zollner H.(1977) Aldehydes in biological systems. In: Lagnado JR, (ed), Aldehydes in biological systems, their natural occurrence and biological activities. Pion Limited, 207 Brondes Bury Park, London pp. 1-7.
109. Scherrer U, Sartori C. (2000) Defective nitric oxide synthesis: A link between metabolic insulin resistance, sympathetic over-activity and cardiovascular morbidity. European Journal of Endocrinology 142: 315-323.
110. Scott I, Duncan W, Ekstrand V. (1963) Purification and properties of glutathione reductase of human erythrocytes. Journal of Biological Chemistry 238: 3928-3939.
111. Searles RL, Sanadi DR. (1960) ?-Ketoglutaric dehydrogenase. Isolation and some properties of a flavoprotein component. Journal of Biological Chemistry 235: 248 5-2491.
112. Sechi LA, Griffin CA, Giacchetti G, Zingaro L, Catena C, Bartoli E,Bartoli E, Schambelan M. (1996) Abnormalities of insulin receptors in spontaneously hypertensive rats. Hypertension 27: 955-961.
113. Selwood T, Thornalley PJ. (1993) Binding of methylglyoxal to albumin and formation of fluorescent adducts. Inhibition by arginine, N-acetylarginine and aminoguanidine. Biochemical Society Transactions 21: 170S.
114. 2+ inoxidant-induced NF-?B activation. Federation of European Biochemical Societies Letters 385: 58-62.
115. Sharma A, Kharb S, Chugh SN, Kakkar R, Singh GR (2000) Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism 49 (2): 160-162.
116. Sharma AM, Schorr U, Distler A. (1993) Insulin resistance in young salt-sensitive normotensive subjects. Hypertension 21:273-279.
117. Shelmet JJ, Reichard GA, Skutches CL, Hoeldtke RD, Owen OE, Boden G. (1988) Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance. Journal of Clinical Investigation 81: 1137-1145.
118. Shih JCH. (1983) Atherosclerosis in Japanese quail and the effect of lipoic acid. Federation Proceedings 42: 2494-2497.
119. Singal PK, Beamish RE, Dhalla NS. (1983), Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Advances in Experimental Medicine and Biology 161: 391-401.
120. Sorrell MD, Ruma DJ. (1987) The functional implications of acetaldehyde binding to cell constitutients. Annals of the New York Academy of Sciences 492: 50-70.
121. Stadtman TC. (1990) Selenium Biochemistry. Annual Review of Biochemistry 59: 111-127.
122. Swanson JE, Laine DC, Thomas W, Bantle JR (1992) Metabolic effects of dietary fructose in healthy subjects. American Journal of Clinical Nutrition 55: 851-856.
123. Swislocki A, Tsuzuki A. (1993) Insulin resistance and hypertension: Glucose intolerance, hyperinsulinemia and elevated free fatty acids in the lean spontaneously hypertensive rat. American Journal of the Medical Sciences 306:282-286
124. Taddei S, Viridus A, Mattei P, Salvetti A. (1993) Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21: 929-933.
125. Taddei S, Salvetti A. (1996) Direct effects of insulin on the arteriolar tone: Abnormality in insulin-resistant states? Nutrition, Metabolism and Cardiovascular Disease 6: 178-186.
126. Takaoka M, Kobayashi Y, Yuba M, Ohkita M, Matsumura Y. (2001) Effects of ?-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats. European Journal of Parmacology 424: 121-129.
127. Thirunavukkarasu V, Anuradha CV, (2004 in press) Influence of ?-lipoic acid on lipid peroxidation and antioxidant defence system in blood of insulin-resistant rats. Diabetes, Obesity and Metabolism 1-8.
128. Thirunavukkarasu V, Nandhini ATA, Anuradha CV. (2003) Lipoic acid restores antioxidant system in tissues of hyperinsulinaemic rats. Indian Journal of Medical Research 118: 134-140.
129. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW. (1989) Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. American Journal of Clinical Nutrition 49:115 5-1163.
130. Thornalley P, Wolff S, Crabbe J, Stern A. (1984) The autoxidation of glyceraldehyde and other simple monosaccharides under physiological conditions catalysed by buffer ions. Biochimica et Biophysica Acta 797: 276-287.
131. Thornalley PJ. (1993) Modification of the glyoxalase system in disease processes and prospects for therapeutic strategies. Biochemical Society Transactions 21: 531-534.
132. Thurich T, Bereiter-Hahn J, Schneider M, Zimmer G. (1998) Cardioprotective effect of dihydrolipoic acid and tocopherol in right heart hypertrophy during oxidative stress. Arzneimittel-Forschung 48: 13-21.
133. Tobey TA, Mondon CE, Zavaroni I, Reaven GM. (1982) Mechanism of insulin resistance in fructose fed rats. Metabolism 31: 608-612.
134. Trovati M, Anfossi G, Massucco R Mattiello L, Costamagna C, Piretto V, Mularoni E, Cavalot F, Bosia A, Ghigo D. (1997) Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3?, 5?- cyclic monophosphate and adenosine-3?, 5?- cyclic monophosphate. Diabetes 46: 742-749.
135. Uchida K, Stadtman ER. (1993) Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydroge-nase. Journal of Biological Chemistry 268: 6388-6393.
136. Uysal M, Bulur H, Sener D, Öz H. (1986) Lipid peroxidation in patients with essential hypertension. International Journal of Clinical Pharmacology, Therapy and Toxicology 24: 474-476.
137. Van Dam PS, van Asbeck BS, van Oirschot JFLM, Biessels GJ, Hamers FPT, Marx JJM. (2001) Glutathione and ?-lipoate in diabetic rats: nerve function, blood flow and oxidative stress. European Journal of Clinical Investigation 31: 417-424.
138. Vander Jagt DL, Hassebrook RK, Hunsaker LA, Brown WM, Royer RE. (2001) Metabolism of the 2-oxoaldehyde methyl-glyoxal by aldose reductase and by glyoxalase-I: roles for glutathione in both enzymes and implications for diabetic complications. Chemical and Biological Interactions 130-132: 549-562.
139. Vander Jagt DL, Hunsaker LA. (1993) Enzymology and Molecular Biology of Carbonyl Metabolism 4, edited by H. Weiner, Plenum Press, N.Y. pp. 279-288.
140. Vander Jagt DL, Hunsaker LA. (2003) Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase.Chemical and Biological Interactions 143-144: 341-351.
141. Varizi ND, Wang XQ Oveisi F, Rad B. (2000) Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36:142-146.
142. Vasdev S, Ford CA, Longerich L, Gadag V, Wadhawan S. (1998a) Role of aldehydes in fructose induced hypertension. Molecular and Cellular Biochemistry 181: 1-9.
143. Vasdev S, Ford CA, Longerich L, Parai S, Gadag V. (1998b) Aldehyde induced hypertension in rats: Prevention by N-acetyl cysteine. Artery 23. 10-36.
144. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V, (2001) Dietary vitamin C supplementation lowers blood pressure in spontaneously hypertensive rats. Molecular and Cellular Biochemistry 218: 97-103.
145. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V (2000a) Dietary ?-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. Journal of Hypertension 18: 567-573.
146. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V (2000b) Dietary lipoic acid supplementation prevents fructose-induced hypertension in rats. Nutrition Metabolism and Cardiovascular Disease 10: 339-346.
147. Vasdev S, Gill V, Longerich L, Parai S, Gadag V. (2003) Salt-induced hypertension in WKY rats: Prevention by ?-lipoic acid supplementation. Molecular and Cellular Biochemistry 254: 319-326.
148. Vasdev S, Gill V, Parai S, Longerich L, Gadag V. (2002a) Dietary vitamin E supplementation lowers blood pressure in spontaneously' hypertensive rats. Molecular and Cellular Biochemistry 238: 111-117.
149. Vasdev S, Gill V, Parai S, Longerich L, Gadag V. (2002b) Dietary vitamin E and C supplementation prevents fructose induced hypertension in rats. Molecular and Cellular Biochemistry 241: 107-114.
150. Vasdev S, Longerich L, Ford CA. (1997) Role of aldehydes in hypertension. In: Sharma BK, Takeda N, Ganguly NK, Singal PK (eds): Adaptation Biology and Medicine (Vol I). New Delhi, India, Narosa Publishing House, pp 326-339.
151. Vasdev S, Mian T, Ford CA, Longerich L, Parai S. (1996b) Role of endogenous aldehydes in spontaneously hypertensive and disulfiram-induced hypertensive rats. Nutrition Metabolism and Cardiovascular Disease 6: 130-140.
152. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. (1986) Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 8 (supp II): II127-II134.
153. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. (1996) Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent Diabetes Mellitus. Journal of the American College of Cardiology 27: 567-574.
154. Wollin SD, Jones PJH. (2003) ?-Lipoic acid and cardiovascular disease. Journal of Nutrition 133: 3327-3330.
155. Wu L, Juurlink BHJ. (2002) Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension 39: 809-814.
156. Yoshioka M, Aoyama K, Matsushita T (1985) Effects of ascorbic acid on blood pressure and ascorbic acid metabolism in spontaneously hypertensive rats (SH rats). International Journal for Vitamin and Nutrition Research 55: 301-307.
157. 2+ release from sarcoplasmic reticulum. via an oxidation reaction. Journal of Biological Chemistry 264: 21725-21736.
158. Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, The DEKAN Study Group, Reichel G. (1997) Effects of treatment with the antioxidant ?-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. Diabetes Care 20: 369-373.
159. Zimmer G, Mainka L, Krüger E. (1991) Diydrolipoic acid activiates oligomycin-sensitive thiol groups and increases ATP synthesis in mitochondria. Archives of Biochemistry and Biophysics 288: 609-613.